
Giorgia Gandolfi developed and maintained advanced bioinformatics pipelines for the caravagnalab/ProCESS-examples repository, focusing on scalable simulation, validation, and reporting workflows for cancer genomics research. She engineered modular data processing and visualization components using R, Nextflow, and Python, enabling reproducible cohort analyses, automated validation, and robust mutation simulation engines. Her work integrated high-performance computing and containerization to streamline batch processing, while enhancing data quality through gender-aware validation, resource tracking, and comprehensive reporting. By refining workflow automation, output management, and visualization—including heatmaps and Sankey plots—Giorgia delivered maintainable, reproducible solutions that improved analytical reliability and supported evolving research requirements.

October 2025 monthly summary focusing on business value and technical achievements for caravagnalab/ProCESS-examples. Highlights include end-to-end ENA submission and FASTQ merging workflow, advanced visualization and reporting for mutational signatures and subclonal evolution, SPN06 mutation simulation engine, and a dependency upgrade to Nextflow process_validation image. No separate bug fixes were required this month; key reliability improvements were achieved through container upgrades and script hardening.
October 2025 monthly summary focusing on business value and technical achievements for caravagnalab/ProCESS-examples. Highlights include end-to-end ENA submission and FASTQ merging workflow, advanced visualization and reporting for mutational signatures and subclonal evolution, SPN06 mutation simulation engine, and a dependency upgrade to Nextflow process_validation image. No separate bug fixes were required this month; key reliability improvements were achieved through container upgrades and script hardening.
September 2025: ProCESS-examples delivered major validation visualization enhancements, robustness improvements, and extended defaults, increasing data quality, reproducibility, and business value. Key outcomes include expanded validation visuals for CNA, somatic mutation, and mutational signatures (heatmaps, Sankey plots, annotations with improved labeling and expanded output for the validation framework); internal robustness improvements to directory handling and VCF output compression; and expanded default coverage options in the sample sheet writer. These changes streamline QA, improve benchmarking reliability (SCOUT benchmarking support), and broaden adoption in clinical and research pipelines.
September 2025: ProCESS-examples delivered major validation visualization enhancements, robustness improvements, and extended defaults, increasing data quality, reproducibility, and business value. Key outcomes include expanded validation visuals for CNA, somatic mutation, and mutational signatures (heatmaps, Sankey plots, annotations with improved labeling and expanded output for the validation framework); internal robustness improvements to directory handling and VCF output compression; and expanded default coverage options in the sample sheet writer. These changes streamline QA, improve benchmarking reliability (SCOUT benchmarking support), and broaden adoption in clinical and research pipelines.
Monthly summary for 2025-08 focused on delivering robust validation workflows (driver and signature) within the ProCESS-examples repository, improving performance visibility, and tightening resource management. The month centered on delivering modular subworkflows, enhancing output structures, adding visualization capabilities, and solidifying robustness for edge cases, with an emphasis on business value through increased accuracy, reliability, and observability.
Monthly summary for 2025-08 focused on delivering robust validation workflows (driver and signature) within the ProCESS-examples repository, improving performance visibility, and tightening resource management. The month centered on delivering modular subworkflows, enhancing output structures, adding visualization capabilities, and solidifying robustness for edge cases, with an emphasis on business value through increased accuracy, reliability, and observability.
July 2025 monthly summary for caravagnalab/ProCESS-examples focused on delivering end-to-end validation enhancements, deployment refinements, and expanded analytical capabilities aligned with the latest ProCESS release. The month emphasized reliability, reproducibility, and business value by upgrading tooling, expanding validation pipelines, and removing deprecated components.
July 2025 monthly summary for caravagnalab/ProCESS-examples focused on delivering end-to-end validation enhancements, deployment refinements, and expanded analytical capabilities aligned with the latest ProCESS release. The month emphasized reliability, reproducibility, and business value by upgrading tooling, expanding validation pipelines, and removing deprecated components.
June 2025 monthly summary for caravagnalab/ProCESS-examples. Delivered a set of pipeline enhancements that improve validation accuracy, automation, and downstream analytical capabilities, with a clear focus on business value and reproducibility. Key features implemented include gender-aware validation with chromosome selection, automation and reporting improvements in the validation workflow, tumour-type annotation and sample association for SCOUT/Cohort analyses, CNA and somatic variant parsing reliability improvements (including Sequenza parsing), and integration of a reference driver mutations dataset (hg38). These changes reduce manual intervention, increase reliability, and enable faster, scalable analyses across cohorts.
June 2025 monthly summary for caravagnalab/ProCESS-examples. Delivered a set of pipeline enhancements that improve validation accuracy, automation, and downstream analytical capabilities, with a clear focus on business value and reproducibility. Key features implemented include gender-aware validation with chromosome selection, automation and reporting improvements in the validation workflow, tumour-type annotation and sample association for SCOUT/Cohort analyses, CNA and somatic variant parsing reliability improvements (including Sequenza parsing), and integration of a reference driver mutations dataset (hg38). These changes reduce manual intervention, increase reliability, and enable faster, scalable analyses across cohorts.
May 2025 monthly summary for the ProCESS-examples repository focusing on delivering automated cohort generation and robust simulation workflows, faster data merging, enhanced validation/reporting, and environment alignment to improve business value and developer efficiency.
May 2025 monthly summary for the ProCESS-examples repository focusing on delivering automated cohort generation and robust simulation workflows, faster data merging, enhanced validation/reporting, and environment alignment to improve business value and developer efficiency.
April 2025 — caravagnalab/ProCESS-examples monthly summary. Focused on delivering scalable, reproducible tumor evolution analytics within the cohort-building workflow, enhancing visualization/reporting, and tightening HPC integration and maintenance. Key deliveries include: 1) Cohort Build Workflow Enhanced with Tumor Evolution Analysis and HPC Integration (refactored benchmark_build_cohort.py, added tumourevo launcher and CSV outputs, aligned package naming to rRACES/ProCESS). 2) Enhanced Plotting and Reporting Capabilities (new plotting for tumor dynamics and signature evolution; fixes for pathing in utils; refined R Markdown report paths; added session reproducibility details to reports). 3) Codebase Cleanup and Script Renaming (SPN01) with removal of obsolete components. 4) Orfeo HPC Configuration Optimization (updated singularity work directory usage; added CNVKIT_BATCH resource configurations) to improve batch processing performance and reliability. Overall, these changes improve reproducibility, scalability, and maintainability while delivering actionable tumor evolution insights to stakeholders.
April 2025 — caravagnalab/ProCESS-examples monthly summary. Focused on delivering scalable, reproducible tumor evolution analytics within the cohort-building workflow, enhancing visualization/reporting, and tightening HPC integration and maintenance. Key deliveries include: 1) Cohort Build Workflow Enhanced with Tumor Evolution Analysis and HPC Integration (refactored benchmark_build_cohort.py, added tumourevo launcher and CSV outputs, aligned package naming to rRACES/ProCESS). 2) Enhanced Plotting and Reporting Capabilities (new plotting for tumor dynamics and signature evolution; fixes for pathing in utils; refined R Markdown report paths; added session reproducibility details to reports). 3) Codebase Cleanup and Script Renaming (SPN01) with removal of obsolete components. 4) Orfeo HPC Configuration Optimization (updated singularity work directory usage; added CNVKIT_BATCH resource configurations) to improve batch processing performance and reliability. Overall, these changes improve reproducibility, scalability, and maintainability while delivering actionable tumor evolution insights to stakeholders.
March 2025 (2025-03) monthly summary for caravagnalab/ProCESS-examples focusing on consolidated simulation configuration/output management and enhanced reporting/visualization. Emphasizes reproducibility, pipeline readiness, and data-driven insights across Sarek/Nextflow and SPN01 outputs.
March 2025 (2025-03) monthly summary for caravagnalab/ProCESS-examples focusing on consolidated simulation configuration/output management and enhanced reporting/visualization. Emphasizes reproducibility, pipeline readiness, and data-driven insights across Sarek/Nextflow and SPN01 outputs.
February 2025 (2025-02): Delivered end-to-end SPN01 reporting and a robust simulation/benchmarking pipeline for the ProCESS-examples project. Key outcomes include an HTML/R Markdown SPN01 report with a table of contents and parameterized inputs, and a significantly enhanced SPN01 workflow with snapshot saving, output directory management, cohort benchmarking, Sarek integration, and merged RDS outputs. These efforts improve reproducibility, data organization, and pipeline reliability, enabling faster experimentation and more rigorous benchmarking.
February 2025 (2025-02): Delivered end-to-end SPN01 reporting and a robust simulation/benchmarking pipeline for the ProCESS-examples project. Key outcomes include an HTML/R Markdown SPN01 report with a table of contents and parameterized inputs, and a significantly enhanced SPN01 workflow with snapshot saving, output directory management, cohort benchmarking, Sarek integration, and merged RDS outputs. These efforts improve reproducibility, data organization, and pipeline reliability, enabling faster experimentation and more rigorous benchmarking.
December 2024 monthly summary for caravagnalab/ProCESS-examples focused on delivering a finalized SPN01 simulation with improved output management and codebase cleanup. The work emphasizes business value through reproducible results, streamlined data outputs, and reduced maintenance overhead.
December 2024 monthly summary for caravagnalab/ProCESS-examples focused on delivering a finalized SPN01 simulation with improved output management and codebase cleanup. The work emphasizes business value through reproducible results, streamlined data outputs, and reduced maintenance overhead.
November 2024 monthly summary for caravagnalab/ProCESS-examples focused on delivering two key features that strengthen visualization capabilities and data handling, enabling faster, more reliable reporting and downstream analyses. What was delivered: - Genome-wide plotting enhancements coupled with upstream data handling refactor to streamline tissue simulation and mutation engine preparation, improving the accuracy and efficiency of reporting and downstream visualization. - A new single-cell heatmap visualization script (CNA and karyotype data) that aggregates data across genomic windows and annotates by sample and clonal information using ComplexHeatmap, expanding single-cell analytics capabilities. Major improvements and impact: - Enhanced reporting readiness and visualization quality, reducing time-to-insight for genomic analyses. - Strengthened data pipelines with upstream handling refinements, contributing to more reproducible analyses and easier pipeline maintenance. Key technologies and skills demonstrated: - R-based data visualization (including ComplexHeatmap) - Genomic data plotting (depth ratio, B-allele frequency, variant allele frequency distributions) - Data pipeline refactoring for tissue simulation and mutation engine preparation Note on bugs: - No major bugs fixed are documented in this data for November 2024; the focus was on feature delivery and pipeline robustness.
November 2024 monthly summary for caravagnalab/ProCESS-examples focused on delivering two key features that strengthen visualization capabilities and data handling, enabling faster, more reliable reporting and downstream analyses. What was delivered: - Genome-wide plotting enhancements coupled with upstream data handling refactor to streamline tissue simulation and mutation engine preparation, improving the accuracy and efficiency of reporting and downstream visualization. - A new single-cell heatmap visualization script (CNA and karyotype data) that aggregates data across genomic windows and annotates by sample and clonal information using ComplexHeatmap, expanding single-cell analytics capabilities. Major improvements and impact: - Enhanced reporting readiness and visualization quality, reducing time-to-insight for genomic analyses. - Strengthened data pipelines with upstream handling refinements, contributing to more reproducible analyses and easier pipeline maintenance. Key technologies and skills demonstrated: - R-based data visualization (including ComplexHeatmap) - Genomic data plotting (depth ratio, B-allele frequency, variant allele frequency distributions) - Data pipeline refactoring for tissue simulation and mutation engine preparation Note on bugs: - No major bugs fixed are documented in this data for November 2024; the focus was on feature delivery and pipeline robustness.
October 2024 monthly summary for caravagnalab/ProCESS-examples: Delivered major improvements to the R-based Simulation and Mutation Analysis Workflow, refactoring experimental parameters and output naming to improve reproducibility and interpretability. Updated growth/death rates for Clone 2 and Clone 4, adjusted run times, and renamed outputs to SPN01_1.2. Enhanced reporting and visualization: refactored the mutation engine, adopted new plotting libraries and color palettes, and tightened sequencing simulation parameter handling to produce clearer phylogenetic trees and mutation data. Codebase cleanup through nomenclature updates. No major bugs fixed this month; focus was on feature work and alignment with the reporting pipeline.
October 2024 monthly summary for caravagnalab/ProCESS-examples: Delivered major improvements to the R-based Simulation and Mutation Analysis Workflow, refactoring experimental parameters and output naming to improve reproducibility and interpretability. Updated growth/death rates for Clone 2 and Clone 4, adjusted run times, and renamed outputs to SPN01_1.2. Enhanced reporting and visualization: refactored the mutation engine, adopted new plotting libraries and color palettes, and tightened sequencing simulation parameter handling to produce clearer phylogenetic trees and mutation data. Codebase cleanup through nomenclature updates. No major bugs fixed this month; focus was on feature work and alignment with the reporting pipeline.
Overview of all repositories you've contributed to across your timeline